Publication | Open Access

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

MedicineGrowth Factor ReceptorReceptor Tyrosine KinasePathologyPrimary ResistanceBronchial NeoplasmTyrosine Kinase InhibitorsCancer TreatmentCancer GeneticsOncologyCell BiologyLung Cancer